Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID‐19)
Journal of Internal Medicine2020Vol. 288(1), pp. 128–138
Citations Over TimeTop 10% of 2020 papers
Jian Wu, W. Li, Xiaowei Shi, Z. Chen, Bin Jiang, J. Liu, D. Wang, C. Liu, Yao Meng, Ligang Cui, Jiong Yu, Hongcui Cao, Lanjuan Li
Abstract
The elderly and patients with underlying diseases are more likely to experience a severe progression of COVID-19. It is recommended that timely antiviral treatment should be initiated to slow the disease progression and improve the prognosis.
Related Papers
- → Return of the Coronavirus: 2019-nCoV(2020)1,427 cited
- → Comorbidity in head and neck cancer: A critical appraisal and recommendations for practice(2010)238 cited
- → Elderly patients with head and neck cancer: the influence of comorbidity on choice of therapy, complication rate, and survival(2005)66 cited
- → SARS-Coronavirus (SARS-CoV)(2009)
- Influence of comorbidity on the choice of treatment and survival of elderly patients with advanced non-small cell lung cancer(2008)